Lv41
450 积分 2025-01-05 加入
Clinically significant portal hypertension (CSPH) on early-stage HCC following hepatectomy: What's the impact?
1天前
已完结
Efficacy and safety of radiotherapy versus transarterial chemoembolization in combination with lenvatinib and camrelizumab for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multicenter study
1天前
已完结
Estimates of the global prevalence of occult hepatitis B virus infection in population under 18 years old: a systematic review and meta-analysis
1天前
已完结
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma
4天前
已完结
The current status and future of targeted-immune combination for hepatocellular carcinoma
9天前
已关闭
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
9天前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
10天前
已完结
Hepatocellular carcinoma systemic treatment 2024 update: from early to advanced stage
19天前
已完结
Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study
1个月前
已完结
NLRP6 deficiency suppresses colorectal cancer liver metastasis growth by modulating M-MDSC-induced immunosuppressive microenvironment
1个月前
已完结
皖公网安备34019202002308
